Carpal Tunnel Syndrome Clinical Trial
Official title:
Diffusion Tensor Imaging of the Median Nerve Before and After Carpal Tunnel Corticosteroid Injection in Patients With Carpal Tunnel Syndrome: Feasibility Study
Carpal tunnel syndrome (CTS) is the most common nerve compression disorder in the upper
extremity. Therapy for carpal tunnel syndrome includes physical and occupational therapy, the
use of splints and other local measures, and corticosteroid injection into the carpal tunnel.
When these measures fail, open surgical release is considered the next step. Although the
main disadvantage of corticosteroid injection is that symptoms are often short-lived relief
and partial relief, it may not provide a permanent solution, corticosteroid injections are
chosen because of lower level of invasiveness, faster recovery, and ease of the technique.
Diffusion tensor magnetic resonance imaging (DTI) reveals tissue microstructure based on
random movements of water molecules. The measured diffusion-weighted images are further
analyzed for parameter images that describe different characteristics of diffusion: apparent
diffusion coefficient (ADC) is an absolute measure of the strength of diffusion, and
fractional anisotropy (FA) describes the asymmetry of the diffusion direction due to tissue
structures. Because the axonal cell membrane and the myelin sheath in nerve fibers prevent
diffusion in the direction which is perpendicular to their fascicles, resulting in the
isotropy of the diffusion of water molecules being lost. DTI is the only method which can
give an indirect view of the microstructure of nervous tissue in addition to the pathway of
the fibers.
DTI has been applied to study peripheral nerves, to demonstrate the feasibility of the method
and to study nerve entrapment in carpal tunnel syndrome (CTS). The previous studies have
demonstrated a decrease in FA in patients with CTS compared to healthy volunteers. The DTI
parameters of the median nerve have revealed significant increase of FA and decrease in ADC
with complete symptom relief 6 months after carpal tunnel release. However, Hiltunen et al.
have demonstrated a significant decrease in ADC but no alter in FA in patients received open
carpal tunnel release 1 year later and felt complete symptoms relief. By means of open carpal
tunnel release, follow-up recordings were made at least 6 months after the operation to
ensure time for post-operative tissue recovery. As a result, the investigators still do not
understand the relevance between the parameters of DTI to symptoms relief in CTS patients
receiving conservative treatment.
Different from carpal tunnel release, steroid injections are popular technique for CTS
treatment and are believed to reduce perineural inflammation or soft tissue swelling, and may
stabilize the neural membrane, thus limiting the ephaptic transmission in ischemic nerve
fibers which causes symptoms. Corticosteroid injections can provide a rapid symptom relief at
2 weeks follow up. However, there is no report addressing the relation of functional change
of median nerve at several anatomic locations to the symptom relief of CTS. Here the
investigators monitored, by means of DTI, median nerve integrity in CTS patients before and
after corticosteroid injection. This information may help to explain the hypothesis regarding
the effect of corticosteroid to the median nerve, to identify which anatomic location of
median nerve relevant to the symptom relief of CTS after corticosteroid injection, and be
useful for the clinical follow-up of patients with nerve entrapments following conservative
treatment.
Study subjects This study was approved by the institutional research ethics board. Written
informed consent was prospectively obtained from all study subjects. Twelve consecutive
patients (nine females, three male; mean age, 56 years; range, 38 to 76 years) suffering from
bilateral CTS referred for consideration of carpal tunnel steroid injection were
prospectively recruited. Inclusion criteria consisted of a clinical diagnosis of unilateral
or bilateral CTS based on a standardized and validated diagnostic scale. The degree of the
entrapment ranged from mild to severe according to the American Association of
Electrodiagnostic Medicine ratings: mild = slowing of sensory conduction velocity (<50 m/s),
moderate = slowing of sensory conduction velocity (<50 m/s) and delayed motor distal latency
(>4 ms), and severe = absence of sensory response. Exclusion criteria included prior carpal
tunnel release or contraindications to MRI. All patients also had the clinical diagnosis
supported by electrodiagnostic investigations.
Ultrasound needle guidance:
The US-guided injection procedure was performed in a standardized manner. The one-needle
two-syringe technique with US guidance was used (1) one needle is used for anesthesia,
hydrodissection, and intra-carpal tunnel injection; (2) the first syringe is used to
anesthetize, hydrodissect, and dilate the intra-carpal tunnel space; and (3) the second
syringe is used to inject the corticosteroid therapy into the new hydrodissected space. After
hydrodissection, the empty lidocaine syringe was detached from the needle while still in the
carpal tunnel, and a 3-ml syringe prefilled with 10 mg triamcinolone acetonide suspension was
attached to the indwelling needle, and the treatment was slowly injected into the
hydrodissected neutral space. The injections were performed in a standardized fashion by a
musculoskeletal radiologist (Y.C.H.) with 13 years of experience in US.
MRI protocol Magnetic resonance images were acquired at 3.0 T (Discovery MR750, GE
Healthcare, Milwaukee, WI, USA) using a 8-channel wrist coil (GE Healthcare, Gainesville, FL,
USA). The coil was at the center of the magnet to maximize the magnetic-field homogeneity.
The subject's hand was fixed with a plastic plate and Velcro tape to the coil to restrict
movements; the subjects were examined in prone position.
For DTI, the investigators recorded non-diffusion-weighted b0 image and 15 diffusion gradient
directions with b = 1,200 s/mm2 from 20 axial slices of 4 mm thickness. Slices were
positioned to cover the whole carpal tunnel and in part the proximal and distal nerve. The
two most proximal and distal slices were excluded from the analysis because of potential bias
caused by the rapid decrease in homogeneity at the edge of the coil. Thus, the total
proximal-distal range examined was 80 mm. The other imaging parameters were as follows:
repetition time (TR) = 10,000 ms, echo time (TE) = 101 ms, number of averages = 3 (during
post-processing), field of view (FOV) = 12 cm and matrix 100 × 80 pixels. The voxel size was
thus 1.46 × 1.46 ×4 mm3.
In addition to DTI, the imaging protocol comprised the following MRI sequences:
1. Axial T2-weighted fast spin echo (FSE): TR = 5,430 ms, TE = 88 ms, echo train length
(ETL) = 16, FOV = 12 cm, matrix 224 × 256 pixels, phase FOV = 0.7, the same slice
positions as in DTI.
2. Axial T1-weighted fast spin echo (FSE): TR = 457 ms, TE = 11~33 ms, flip angle = 110°,
FOV = 12 cm, matrix 384 × 256 pixels, phase FOV = 0.7, the same slice positions as in
DTI.
Data collection:
The patients' medical records were reviewed by a neurologist (F.C.Y.). Routinely, the
investigators recorded clinical data (including sex, age, and side of injection, and the
effect of treatment. The satisfaction scale of patients was rated using a Likert scale: 5 =
greatly satisfactory; 4 = some residual symptoms and satisfaction > 50%; 3 = some residual
symptoms and satisfaction = 50% ; 2 = residual symptoms and satisfaction < 50%; 1=
unsatisfactory. Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) is the most commonly used
questionnaire for the measurement of the severity of symptoms and functional status with
reproducibility, internal consistency, and validity in patients with CTS. The symptom
severity subscale of BCTQ consists of 11 questions with scores from 1 point (mildest) to 5
points (most severe), and the functional status of BCTQ subscale is made up of 8 questions
with scores from 1 point (no difficulty in activity) to 5 points (unable to perform the
activity at all). Patients were seen in the subsequent clinical visit to determine outcomes.
The investigators also recorded the decrement of BCTQ between the pre-injection and
post-injection.
Data analysis Two investigators (Y.C.H., H.Y.C.) with experience in peripheral nerve imaging
assessed the quality of the DTI source data. No case with visible motion artefacts was
identified. Eddy current induced distortion occasionally appeared on the very proximal
imaging planes, but did not affect the measurement regions. The DTI source data was post
processed using the commercial post-processing workstation (GE Healthcare, ADW4.5). The
investigators blinded to clinical data, side, and time point relative to steroid injection
randomly performed all measurements. The same author performed a second blinded analysis of
all acquired datasets after a 2-week period. Raw DTI data was initially reviewed with regard
to image quality and occurrence of artefacts. After performing the GE Workspace imaging
co-registration of EPI images for motion correction (through plane), DTI-based tractography
(DTT) of the median nerve was performed. By defining at least two seed points, fibers passing
in anterograde and retrograde direction followed a streamline algorithm and terminated if FA
values were below 0.15 or if there were angle changes over 27°. The median nerve was
visualized using at least three different attempts with two ROIs placed at different slice
positions along the nerve (covering the entire imaged carpal tunnel). The 3D course of the
nerve was tracked with DTT computed with the FACT algorithm (Fiber Assignment by Continuous
Tracking).
Fractional anisotropy (FA) and the apparent diffusion coefficient (ADC) were measured
bilaterally at each time point. FA and ADC were calculated from free-hand regions of interest
(ROIs) placed in the center of the median nerve at three levels: at the level of the distal
radioulnar joint (the most proximal slice where by the distal radio ulnar joint was
visualized) and at the level of the flexor retinaculum (level of the pisiform). To avoid
partial volume artifacts, care was taken to draw the ROIs slightly smaller than the
cross-sectional area of the median nerve. The size of the ROIs depended on the
cross-sectional area of the nerve and all ROIs were placed on one slice only. Anatomic
reference images were used to identify the median nerve. The measurement of each parameter
was repeated three times and the mean was calculated. Representative images are presented.
Regarding the assessment of DTT, the investigators determined the nerve fiber tractography by
morphology. Four different nerve trajectory patterns were defined by Breitenseher et al.: (1)
If there was no alteration of the peripheral nerve trajectories, the pattern was rated
"continuous". (2) If the trajectories were continuous, but irregularly organized, peripheral
nerve tractography result was rated "deranged" .(3) In cases where only some of the ulnar
nerve trajectories were interrupted in one peripheral nerve segment, the finding was defined
as "partially discontinuous ". (4) If there was a complete discontinuity of all trajectories
and a "gap" on at least one plane, tractography was classified as "completely discontinuous".
DTT images were evaluated by two readers (Y.C.H., G.S.H.) in consensus.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05067205 -
Minimal Invasive Carpal Tunnel Release With the Novel Device
|
N/A | |
Completed |
NCT03184688 -
Platelet Rich Plasma for Carpal Tunnel Syndrome
|
N/A | |
Completed |
NCT03582735 -
Preoperative Neuromobilization Exercises for Individuals With Carpal Tunnel Syndrome
|
N/A | |
Completed |
NCT05490420 -
Effects of Upper Extremity Manual Lymphatic Drainage on Symptom Severity, Hand Functions, Electrophysiological and Ultrasonographic Measurements in Carpal Tunnel Syndrome
|
N/A | |
Recruiting |
NCT05970692 -
Cross-Cultural Adaptation and Psychometric Validation of the Turkish Version of Atroshi-Lyrén 6-item Symptoms Scale
|
||
Completed |
NCT04043780 -
Clinical Validation of a Decompression Prototype Splint for Patients With Carpal Tunel Syndrome
|
N/A | |
Completed |
NCT03880812 -
Cost Information on Carpal Tunnel Syndrome Treatment Decisions
|
N/A | |
Completed |
NCT06464809 -
Treatment Intervention of Patients With Carpal Tunnel Syndrome (CTS)
|
N/A | |
Recruiting |
NCT05503719 -
An Absorbable Suture Versus a Non-absorbable Suture in Carpal Tunnel Release, a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT05328180 -
aDjunct bicarbonatE in Local anaesthesIa for CarpAl Tunnel rElease (DELICATE)
|
N/A | |
Recruiting |
NCT05372393 -
Carpal Tunnel Release Under Local Anaesthesia With or Without Distal Median Nerve Block
|
N/A | |
Recruiting |
NCT05466162 -
Soft Tissue Massage Along With Mobilization Technique on Symptoms and Functional Status of Carpal Tunnel Syndrome
|
N/A | |
Completed |
NCT04060875 -
Research Protocol for Karuna Labs Inc.: Safety and Efficacy of Virtual Reality Graded Motor Imagery for Chronic Pain
|
||
Not yet recruiting |
NCT06294821 -
4AP to Delay Carpal Tunnel Release (CTR)
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT04328805 -
Pain Reduction and Changes in Upper Limb Function Produced by an Ibuprofen Treatment in Carpal Tunnel Syndrome.
|
Phase 4 | |
Terminated |
NCT02791529 -
Scalpel Versus Electrocautery for Surgical Skin Incision in Open Carpal Tunnel Release
|
Phase 1 | |
Completed |
NCT02141035 -
Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome
|
Phase 2/Phase 3 | |
Completed |
NCT01887145 -
Comparison of Long-term Outcomes Following Endoscopic or Open Surgery for Carpal Tunnel Syndrome
|
N/A | |
Recruiting |
NCT01897272 -
Post-Operative Splinting After Short-Incision Carpal Tunnel Release: a Prospective Study
|
N/A | |
Completed |
NCT01394822 -
Neuromuscular Ultrasound for Focal Neuropathies
|
N/A |